Global cDNA Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global cDNA Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

cDNA Synthesis describes the generation of complementary DNA (cDNA) from an RNA template by reverse transcription. Reverse transcriptases (RTs) use an RNA template and a primer complementary to the RNA to direct the synthesis of the first strand cDNA, which can be used directly as a template for the Polymerase Chain Reaction (PCR).

Market Overview:

The latest research study on the global cDNA Synthesis market finds that the global cDNA Synthesis market reached a value of USD 70.05 million in 2022. It’s expected that the market will achieve USD 133.34 million by 2028, exhibiting a CAGR of 11.32% during the forecast period.

Market Drivers

In molecular biology, complementary DNA (cDNA) is synthesized from RNA template in a reaction catalyzed by the enzyme reverse transcriptase (RTase). cDNA synthesis is the first step in many molecular biology workflows, such as gene expression research using real-time PCR. cDNA is also used for gene cloning and the creation of cDNA libraries. Accurate and precise results of these applications require high fidelity of cDNA synthesis, so that the cDNA library can accurately represent the original RNA transcript. The choice of enzyme affects the synthesis rate and the fidelity of the reaction. The priming strategy affects the content transcribed in the reaction, and if it is not optimal, may result in a biased library that does not accurately represent the complete transcriptome. cDNA synthesis is widely used in various fields, and the growing demand in downstream fields will promote the development of cDNA Synthesis industry.
In developed markets, there are more international companies, good channels, high market maturity, fierce competition among industries, and market expansion among enterprises through mergers and acquisitions. The company's high-quality management team, technical and financial advantages, continuous innovation, highlighting the large investment of market participants in R&D, the introduction of new technologies, the company's product development and innovation, created the company's brand effect, and improved its international popularity. All these factors will promote the growth of market demand for cDNA Synthesis, thus promoting the development of the industry.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

Thermo Fisher Scientific is one of the major players operating in the cDNA Synthesis market, holding a share of 20.29% in 2022.

Thermo Fisher Scientific Inc. is the world leader in serving science. Global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

For over 50 years, Takara Bio has been committed to helping scientists break new ground with innovative technologies. Its extensive portfolio of reagents, instruments, and services support advancements in the life sciences, including frontline diagnostics and clinical applications.

Segmentation Overview:

Among different product types, Oligonucleotide Synthesis segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Pharmaceutical & Biotechnology Companies segment occupied the biggest share from 2018 to 2022.

Key Companies in the global cDNA Synthesis market covered in Chapter 3:

Agilent
Thermo Fisher Scientific
Roche
Takara Bio
New England Biolabs
QIAGEN
Bio-Rad Laboratories
TATAA Biocenter
Bioline

In Chapter 4 and Chapter 14.2, on the basis of types, the cDNA Synthesis market from 2018 to 2029 is primarily split into:

Oligonucleotide Synthesis
Gene Synthesis

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the cDNA Synthesis market from 2018 to 2029 covers:

Academic Institutes
Hospitals
Pharmaceutical & Biotechnology Companies
Research Centers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)